Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity
新辅助卡博替尼和纳武单抗治疗可将局部晚期肝细胞癌转化为可切除疾病,并增强抗肿瘤免疫力
期刊:Nature Cancer
影响因子:23.5
doi:10.1038/s43018-021-00234-4
Won Jin Ho #, Qingfeng Zhu #, Jennifer Durham, Aleksandra Popovic, Stephanie Xavier, James Leatherman, Aditya Mohan, Guanglan Mo, Shu Zhang, Nicole Gross, Soren Charmsaz, Dongxia Lin, Derek Quong, Brad Wilt, Ihab R Kamel, Matthew Weiss, Benjamin Philosophe, Richard Burkhart, William R Burns, Chris S